SHEILA GUJRATHI
CIK 1575202 · President & CEO · last filed 2026-03-04
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$2.30M
Companies
7
Total Filings
33
Lifetime Open-Market Net
-$8.02M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Ventyx Biosciences, Inc. (VTYX) Delisted | Director | 0 | $13.99 | $0 | -$3.07M | 11 | 2026-03-04 |
| JANX | Director | 118,889 | $13.56 | $1.61M | $0 | 6 | 2025-06-13 |
| Turning Point Therapeutics, Inc. (TPTX) Delisted | Director | — | $76.01 | — | $0 | 2 | 2020-06-17 |
| GOSS | President & CEO | 4,237,742 | $0.16 | $686.1K | $168.0K | 4 | 2020-02-19 |
| FIVE PRIME THERAPEUTICS, INC. (XLRN) Delisted | Director | — | $178.75 | — | $0 | 3 | 2018-05-14 |
| FIVE PRIME THERAPEUTICS, INC. (FPRX) Delisted | Director | — | $38.00 | — | $0 | 1 | 2015-12-03 |
| Receptos, Inc. (RCPT) Delisted | Chief Medical Officer | 12,500 | — | — | -$5.11M | 6 | 2015-08-27 |
Recent Filings · Page 2 of 4
33 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-06-12 | Ventyx Biosciences, Inc. (VTYX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-04-26 | Ventyx Biosciences, Inc. (VTYX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-03-31 | Ventyx Biosciences, Inc. (VTYX) Delisted | Mixed | — | -$2.77M | EDGAR |
| 2022-06-16 | JANX | Grant (A) | — | $0 | EDGAR |
| 2022-06-10 | Ventyx Biosciences, Inc. (VTYX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-12-03 | Ventyx Biosciences, Inc. (VTYX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-10-25 | Ventyx Biosciences, Inc. (VTYX) Delisted | Conv (C) | +32,897 | $0 | EDGAR |
| 2020-06-17 | Turning Point Therapeutics, Inc. (TPTX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-02-19 | GOSS | Grant (A) | +189,500 | $0 | EDGAR |
| 2019-09-27 | GOSS | Buy (P) | +10,000 | $168.0K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.